TITLE

What is the Best Treatment for a Cancer Patient with Thrombosis?

AUTHOR(S)
Barbosa, Miguel
PUB. DATE
January 2014
SOURCE
Clinical Medicine Insights: Oncology;2014, Issue 8, p49
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The relationship between venous thromboembolism and cancer has been known for many years, and there is solid scientific evidence addressing the adequate treatment of this condition in oncology patients. However, established prescribing habits, individual patient challenges, and uncertainty concerning treatment justifies poor adherence to published guidelines. This paper reviews venous thromboembolism treatment while focusing on vitamin K antagonists, low-molecular-weight heparins, and novel oral anticoagulants, namely in terms of their efficacy and limitations.
ACCESSION #
99995074

 

Related Articles

  • Prevention of Thrombosis in Gynecologic Malignancy. Heilmann, Lothar; Tempelhoff, Georg-Friedrich V.; Schneider, Dirk // Clinical & Applied Thrombosis/Hemostasis;Jul1998, Vol. 4 Issue 3, p153 

    Provides information on the prevention of thrombosis in gynecologic malignancy. Pathogenesis of thrombosis in cancer; Incidence of deep vein thrombosis (DVT) in gynecologic patients; Treatment of DVT in cancer patients.

  • Superior Ophthalmic Vein Thrombosis in a Patient with Chronic Myeloid Leukemia Receiving Antifibrinolytic and Thrombopoietin Receptor Agonist Therapy. Shinder, Roman; Oellers, Patrick; Esmaeli, Bita; Schiffman, Jade S. // Journal of Ocular Pharmacology & Therapeutics;Jun2010, Vol. 26 Issue 3, p293 

    Isolated superior ophthalmic vein (SOV) thrombosis is a rare condition usually related to inflammation of the orbit or paranasal sinuses.1–3 Patients present with acute orbital signs, including proptosis, ophthalmoplegia, globe dystopia, and periorbital edema, and may have diminished...

  • NCCN Issues First Guidelines for Deep Vein Thrombosis Treatment in Cancer Patients. Susman, Ed // JNCI: Journal of the National Cancer Institute;4/19/2006, Vol. 98 Issue 8, p515 

    The article provides information on the first guidelines for deep vein thrombosis treatment issued by National Comprehensive Cancer Network organization in the U.S. The guideline addresses several topics such as venous thromboembolism treatment for cancer patients, development of deep vein...

  • Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs. Junli Xue; Xie, Victoria K.; Peipei Wang; Jiujie Cui; Yong Gao; Zhimin Lu // Current Pharmaceutical Design;Oct2014, Vol. 20 Issue 33, p5298 

    Metastasis and thrombosis are serious threats to cancer patients and generally associated with poor prognosis. The elusive mechanisms underlying the pathogenesis of metastasis and thrombosis have been subjects of extensive investigations. The presence of circulating tumor cells (CTCs) is closely...

  • Warfarin.  // Reactions Weekly;4/8/2006, Issue 1096, p26 

    Discusses the case of a woman who developed hemorrhage during treatment with warfarin for thrombosis prophylaxis and concomitant capecitabine for breast cancer. Treatment received by the patient for the complication; Comment on the effects of warfarin on the patient.

  • Venous thromboembolism: not as easy as it looks. Johnson, Miriam J. // British Journal of Hospital Medicine (17508460);Jul2009, Vol. 70 Issue 7, p374 

    The author reflects on the risk of venous thromboembolism on patients with cancer in Great Britain. She notes that the risk of cancer patient developing venous thromboembolism is increased by many anti-cancer chemotherapies. She stresses that awareness of the complex interaction between cancer,...

  • Thrombophilia in Malignancy: A Review of the literature. Huβain, Sakeer // Internet Journal of Internal Medicine;2009, Vol. 8 Issue 1, p22 

    Hypercoagulable state is a well recognized complication of malignancy. Venous thrombosis manifests mainly as deep venous thrombosis or pulmonary embolism. Autopsy studies have reported increased rates of pulmonary embolism among cancer patients as compared to patients without malignancy.[1] The...

  • Thrombophilia in Malignancy: A Review of the literature. Hussain, Sakeer // Internet Journal of Oncology;2009, Vol. 6 Issue 2, p25 

    Hypercoagulable state is a well recognized complication of malignancy. Venous thrombosis manifests mainly as deep venous thrombosis or pulmonary embolism. Autopsy studies have reported increased rates of pulmonary embolism among cancer patients as compared to patients without malignancy.[1] The...

  • TROMBOZA ACUTÄ‚ DE VENÄ‚ CAVÄ‚ SUPERIOARÄ‚, O COMPLICAÅ¢IE DE TEMUT LA PACIENÅ¢II ONCOLOGICI CU CAMERÄ‚ DE PERFUZIE. Orlov, C.; Silişte, R.; Grama, F.; Ianula, R.; Spătaru, D.; Zaharia, C.; Pătru, R.; Isacoff, D. // Internal Medicine / Medicina Interna;2015, Vol. 12 Issue 4, p81 

    Central venous catheters are widely used in the treatment of cancer patients because they facilitate the administration of chemotherapy over long periods of time. Although they have improved the management of these patients, they have a considerable potential for serious complications,...

  • Thromboembolic Disorders in Cancer. Van Gerpen, Ruth; Mast, Merle E. // Clinical Journal of Oncology Nursing;Jun2004, Vol. 8 Issue 3, p289 

    Complex factors, including substances in cancer cells, cancer treatment effects, and venous stasis associated with chronic illness, blood vessel wall injury, and immobility, interact to place patients with cancer at risk for thrombosis. This article describes the etiology, clinical...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics